Olanzapine is an atypical antipsychotic that, in addition to its use in adults, is now indicated for the treatment of schizophrenia, and manic or mixed episodes associated with bipolar I disorder in adolescents aged 13-17 years.
[McCormack PL. CNS Drugs. 2010 May 1;24(5):443-52.]
Shows appreciable efficacy in Huntington's disease with better side effect profile.
Newer antipsychotic agents such as olanzapine and aripiprazole may have adequate efficacy with a more favourable adverse-effect profile than older antipsychotics for treating chorea and psychosis.
[Frank S, Jankovic J. Drugs. 2010 Mar 26;70(5):561-71]
Also indicated in :
- Schizophrenia
- Bipolar disorder
- Entomophobia
- Amphetamine psychosis
- Delusional parasitosis